ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 154751 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 154751; 2) Community: the network communities that were significantly associated with the response to NSC 154751; 3) Molecule: the relationships between components within communities and NSC 154751; 4) MDR: the compounds that were significantly associated with the NSC 154751.

NSC Compound Enrichment Correlation
NSC 1433 4-(BUTYLAMINO)-1-PHENYL-1H-PYRAZOLO[3,4-D]PYRIMIDINE 0.0386895225700407 0.67575736
NSC 159631 Ergochrome AA (2,2')-5-.beta.,6-.alpha.,10-.beta.-5',6'-.alpha.,10'-.beta. 0.0386895225700413 0.22877967
NSC 175633 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- 0.0386895225700413 0.64237156
NSC 176503 Fastigilin B 0.0386895225700413 0.37408578
NSC 180973 Tamoxifen citrate 0.0386895225700413 0.28980304
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0386895225700413 0.25890279
NSC 201290 Octadecanamide, N-(1.beta.-D-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- 0.0386895225700413 0.32823727
NSC 245456 Naphthalene, 2,3-dimethoxy-6-(2-nitroethenyl)- 0.0386895225700413 0.11169728
NSC 266491 Psorspermin 0.0386895225700413 0.38084574
NSC 278631 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- 0.0386895225700413 -0.035368105
Total:146  Current:120    [First] [Prev] [Next] [Last]